Addressing the Diagnostic Challenges of Acute Myocardial Infarction (AMI): Speed and Accuracy are Key
Early and accurate diagnosis of acute myocardial infarction (AMI) is crucial for timely initiation of reperfusion therapy, saving ischemic myocardium, and improving patient prognosis. Authoritative bodies such as the European Society of Cardiology (ESC) emphasize in their guidelines the central role of high-sensitivity cardiac troponin (hs-cTn) in rapid AMI diagnostic pathways (such as the 0/1 hour or 0/2 hour algorithm). High-sensitivity troponin I (hs-cTnI) assays can detect subtle myocardial injury earlier and more accurately, providing clinicians with critical decision-making information.
Advantages of reOpenTest High-Sensitivity cTnI Assay
Compliant with ESC guidelines
Designed specifically to meet the performance requirements of international guidelines such as ESC for hs-cTn assays in rapid AMI diagnostic pathways, supporting 0/1h or 0/2h rapid rule-out or rule-in strategies.
High Sensitivity and High Precision
Able to detect very low concentrations of cTnI, detect myocardial injury earlier, and has excellent detection precision.
Rapid Results (POCT)
Point-of-care testing (POCT) platform that provides results in a short time (e.g., 15-20 minutes) to aid rapid emergency department decision-making.
Optimize AMI Diagnosis and Treatment Process
Helps to quickly and accurately stratify risk in patients with chest pain, identify high-risk AMI patients, safely rule out low-risk patients, and optimize the allocation of medical resources.
Clinical Applications and Value
reOpenTest high-sensitivity cTnI rapid assay is mainly used for:
- Rapid diagnosis and exclusion of suspected acute coronary syndrome (ACS), especially AMI patients, in the emergency department.
- Risk stratification and prognosis assessment of patients with chest pain.
- Monitoring the degree and dynamic changes of myocardial injury.
- Guiding the assessment and management of perioperative myocardial injury.
By achieving rapid and accurate detection of hs-cTnI on the POCT platform, reOpenTest is committed to providing clinicians with more powerful tools to address the challenges of critical cardiovascular diseases such as AMI and improve patient outcomes.
Related Cardiac Marker Detection Solutions
Obtain High-Sensitivity cTnI Assay Solutions
Learn more about reOpenTest high-sensitivity cTnI rapid assay products and their application details in AMI diagnosis and risk stratification.
Contact Us